coumarin has been researched along with troxerutin in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
al-Nawas, B; Belz, GG; Bockisch, A; Grötz, KA; Henneicke-von Zepelin, HH; Kohnen, R; Kutzner, J; Naser-Hijazi, B; Wagner, W; Wüstenberg, P | 1 |
Burian, M; Freudenstein, J; Henneicke-von Zepelin, HH; Legrum, W; Naser-Hijazi, B; Tegtmeier, M | 1 |
Becker, EW; Henneicke-von Zepelin, HH; Naser-Hijazi, B; Schmeck-Lindenau, HJ; Schnitker, J | 1 |
Adam, BS; Pentz, R; Siegers, CP; Strubelt, O; Tegtmeier, M | 1 |
Aun, R; Belczak, SQ; Beserra, J; Campos, W; Nering, G; Sincos, IR | 1 |
4 trial(s) available for coumarin and troxerutin
Article | Year |
---|---|
[Prospective double-blind study of prophylaxis of radioxerostomia with Coumarin/Troxerutine in patients with head and neck cancer].
Topics: Adult; Aged; Coumarins; Double-Blind Method; Drug Therapy, Combination; Female; Head and Neck Neoplasms; Humans; Hydroxyethylrutoside; Male; Middle Aged; Mouth Mucosa; Prospective Studies; Radiation Injuries; Radiation-Protective Agents; Radiotherapy; Salivation; Treatment Outcome; Xerostomia | 1999 |
Single copy of variant CYP2A6 alleles does not confer susceptibility to liver dysfunction in patients treated with coumarin.
Topics: Adult; Aged; Anticoagulants; Aryl Hydrocarbon Hydroxylases; Chemical and Drug Induced Liver Injury; Coumarins; Cytochrome P-450 CYP2A6; Double-Blind Method; Drug Combinations; Female; Gene Frequency; Genotype; Humans; Hydroxyethylrutoside; Liver Diseases; Liver Function Tests; Male; Middle Aged; Mixed Function Oxygenases; Polymorphism, Genetic; Prospective Studies; Smoking; Venous Insufficiency | 2003 |
Safety aspects of a coumarin-troxerutin combination regarding liver function in a double-blind placebo-controlled study.
Topics: Aged; Alanine Transaminase; Alkaline Phosphatase; Anticoagulants; Aspartate Aminotransferases; Coumarins; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; gamma-Glutamyltransferase; Humans; Hydroxyethylrutoside; Liver; Male; Middle Aged | 2003 |
Veno-active drugs for chronic venous disease: A randomized, double-blind, placebo-controlled parallel-design trial.
Topics: Biomechanical Phenomena; Brazil; Cardiovascular Agents; Chronic Disease; Coumarins; Diosmin; Double-Blind Method; Drug Therapy, Combination; Edema; Female; Foot Joints; Hesperidin; Humans; Hydroxyethylrutoside; Male; para-Aminobenzoates; Plethysmography; Quality of Life; Range of Motion, Articular; Recovery of Function; Surveys and Questionnaires; Time Factors; Treatment Outcome; Venous Insufficiency | 2014 |
1 other study(ies) available for coumarin and troxerutin
Article | Year |
---|---|
Troxerutin protects the isolated perfused rat liver from a possible lipid peroxidation by coumarin.
Topics: Alanine Transaminase; Animals; Anticoagulants; Bile; Chemical and Drug Induced Liver Injury; Coumarins; Glutamate Dehydrogenase; Hydroxyethylrutoside; L-Lactate Dehydrogenase; Lipid Peroxidation; Male; Melilotus; Phytotherapy; Plant Extracts; Protective Agents; Rats; Rats, Wistar | 2005 |